Berman W, Musselman J, Shortencarrier R
J Pharmacokinet Biopharm. 1982 Apr;10(2):173-86. doi: 10.1007/BF01062334.
The pharmacokinetics of digoxin were determined in 12 ewes and 13 newborn sheep after bolus drug administration and under steady state drug conditions. After death, tissue distribution of digoxin was determined and normalized to plasma drug concentrations at steady state. Volume of distribution and total drug clearance were lower at steady state than the comparable variables calculated from bolus drug administration. No significant difference between ewes and newborns was shown for drug distribution half-life (0.72 vs. 0.76 hr), drug elimination half-life (15.2 vs. 13.7), or renal drug clearance (0.86 vs. 0.89 liters/kg/hr). Total drug clearance as well as the area derived and steady state volumes of distribution were higher in newborns than in ewes. Digoxin secretion into the urine was limited in newborns, as evidenced by a lower renal digoxin clearance to creatinine clearance ratio in newborns than in ewes (371 vs. 600%). The plasma concentration of digoxin at steady state correlated well with myocardial drug concentrations. Drug distribution was similar in both age groups; however, the tissue to plasma digoxin ratio in kidney was higher in newborns than in ewes (mean 469 vs. 263, respectively). Although age-related differences in drug clearance and distribution volume existed, intersubject variation was substantial, and the demonstrated variations were not large enough to account for the high doses of digoxin used to treat congestive heart failure in immature subjects.
在12只母羊和13只新生绵羊中,在单次推注给药后和药物稳态条件下测定了地高辛的药代动力学。死亡后,测定了地高辛的组织分布,并将其归一化为稳态时的血浆药物浓度。稳态时的分布容积和总药物清除率低于根据单次推注给药计算的可比变量。母羊和新生绵羊在药物分布半衰期(0.72小时对0.76小时)、药物消除半衰期(15.2小时对13.7小时)或肾脏药物清除率(0.86升/千克/小时对0.89升/千克/小时)方面未显示出显著差异。新生绵羊的总药物清除率以及推导的面积和稳态分布容积均高于母羊。新生绵羊尿液中地高辛的分泌有限,这一点可通过新生绵羊的肾脏地高辛清除率与肌酐清除率之比低于母羊得到证明(分别为371%对600%)。稳态时地高辛的血浆浓度与心肌药物浓度密切相关。两个年龄组的药物分布相似;然而,新生绵羊肾脏中地高辛的组织与血浆之比高于母羊(分别平均为469对263)。尽管在药物清除率和分布容积方面存在与年龄相关的差异,但个体间差异很大,而且所显示的差异不足以解释用于治疗未成熟受试者充血性心力衰竭的高剂量地高辛。